Raymond James Financial Services Advisors’s Cascadian Therapeutics, Inc. CASC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2016
Q4
Sell
-2,542
Closed -$25K 2430
2016
Q3
$25K Buy
+2,542
New +$25K ﹤0.01% 2217